公开(公告)号：US20240239766A1

公开(公告)日：2024-07-18

申请号：US18584298

申请日：2024-02-22

申请人： Genentech, Inc.

发明人： Steven John MCKERRALL ,  Daniel Fred ORTWINE ,  Philippe BERGERON ,  Ramsay BEVERIDGE ,  Elise GHIRO ,  Kwong Wah LAI ,  Guqin SHI

IPC分类号： C07D401/12 ,  A61K31/454 ,  A61K31/506 ,  A61P17/04 ,  A61P29/00 ,  C07D401/14 ,  C07D405/14 ,  C07D413/12 ,  C07D417/12

CPC分类号： C07D401/12 ,  A61K31/454 ,  A61K31/506 ,  A61P17/04 ,  A61P29/00 ,  C07D401/14 ,  C07D405/14 ,  C07D413/12 ,  C07D417/12

摘要： The invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Z1, Z2, R3-R8, RA, ring A, and n have the meanings described herein, and compositions containing such compounds and methods for using such compounds and compositions for the treatment of pain.

公开(公告)号：US20240228463A1

公开(公告)日：2024-07-11

申请号：US18584311

申请日：2024-02-22

申请人： Genentech, Inc.

发明人： Marc KSCHONSAK ,  Steven John MCKERRALL ,  Daniel Fred ORTWINE ,  Jian Mehr-Dean PAYANDEH ,  Benjamin Douglas SELLERS ,  John C. TELLIS ,  Matthew VOLGRAF ,  Philippe BERGERON ,  Claudio CIFERRI ,  Peter Scott DRAGOVICH

IPC分类号： C07D401/12 ,  A61K31/18 ,  A61P25/04 ,  C07C311/51 ,  C07D211/96 ,  C07D277/44 ,  C07D277/82 ,  C07D295/26 ,  C07D471/04 ,  C07D487/04 ,  C07D498/04

CPC分类号： C07D401/12 ,  A61K31/18 ,  A61P25/04 ,  C07C311/51 ,  C07D211/96 ,  C07D277/44 ,  C07D277/82 ,  C07D295/26 ,  C07D471/04 ,  C07D487/04 ,  C07D498/04

摘要： The invention provides compounds of formulae I, II, IIa, and III:




and pharmaceutically acceptable salts thereof, as well as compositions containing such compounds and methods for using such compounds and compositions.

公开(公告)号：US20240174696A1

公开(公告)日：2024-05-30

申请号：US18526572

申请日：2023-12-01

申请人： Genentech, Inc.

发明人： Steven John MCKERRALL ,  Alice Rose WONG ,  James John CRAWFORD ,  Wendy LEE ,  Kwong Wah LAI ,  Guillaume PELLETIER ,  Stéphanie ROY ,  Dana Krystin WINTER ,  Mikiko OKUMURA ,  Ruth Dorel

IPC分类号： C07D519/00 ,  A61P11/00

CPC分类号： C07D519/00 ,  A61P11/00

摘要： Disclosed are 2,8-diazaspiro[4.5]decane compounds, including (pyrido[3,4-d]pyrimidin-4-yl)-2,8-diazaspiro[4.5]decane compounds, (2,6-naphthyridin-1-yl)-2,8-diazaspiro[4.5]decane compounds, and (1,7-naphthyridin-4-yl)-2,8-diazaspiro[4.5]decane compounds, that are inhibitors of LATS1/2, compositions containing these compounds, and methods for inhibiting LATS1/2 activity.